[1] Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract, 2019; 157, 107843. doi:  10.1016/j.diabres.2019.107843
[2] Wang SK, Ji XK, Zhang ZT, et al. Relationship between lipid profiles and glycemic control among patients with type 2 diabetes in Qingdao, China. Int J Environ Res Public Health, 2020; 17, 5317. doi:  10.3390/ijerph17155317
[3] Li YZ, Teng D, Shi XG, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ, 2020; 369, m997.
[4] Li SN, Zhang LF, Wang X, et al. Status of dyslipidemia among adults aged 35 years and above in China. Chin Circ J, 2019; 34, 681−7. (In Chinese
[5] Bai YN, Yang AM, Pu HQ, et al. Cohort profile: the china metal-exposed workers cohort study (Jinchang Cohort). Int J Epidemiol, 2017; 46, 1095−6e.
[6] American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care, 2018; 41, S13−27. doi:  10.2337/dc18-S002
[7] Lee JS, Chang PY, Zhang Y, et al. Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: the strong heart study. Diabetes Care, 2017; 40, 529−37. doi:  10.2337/dc16-1958
[8] van Linthout S, Spillmann F, Schultheiss HP, et al. High-density lipoprotein at the interface of type 2 diabetes mellitus and cardiovascular disorders. Curr Pharm Des, 2010; 16, 1504−16. doi:  10.2174/138161210791051031
[9] Sun K, Xu MQ, Wang XJ, et al. Overweight and obesity among low-income uygur peasants in china’s far western Xinjiang: correlations between body mass index and blood lipids. Chin J Biochem Mol Biol, 2020; 36, 71−8. (In Chinese